What is the treatment for postpartum depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Postpartum Depression

Postpartum depression (PPD) requires a combination of psychotherapy and antidepressant medication for moderate to severe cases, with screening using the Edinburgh Postnatal Depression Scale (EPDS) as the first step in management. 1

Screening and Diagnosis

  • The Edinburgh Postnatal Depression Scale (EPDS) is the recommended primary screening tool for PPD with class A recommendation based on adequate content validity and sufficient internal consistency 2, 1
  • PPD affects approximately 15% of women during the first postpartum year 1
  • Key risk factors to assess during screening:
    • Severe life events and chronic stress 2, 1
    • Poor relationship quality, especially with partner and mother 2, 1
    • Low levels of social support 1
    • History of mood or anxiety disorders (strongest risk factor) 3
    • Intimate partner violence or family conflict 1

Treatment Algorithm

Step 1: Assess Severity

  • Use EPDS score to determine severity:
    • Mild: EPDS score 10-12
    • Moderate: EPDS score 13-16
    • Severe: EPDS score >16 or with suicidal/homicidal ideation

Step 2: Select Treatment Based on Severity

For Mild PPD:

  • First-line: Individual or group-based interpersonal therapy 1
  • Focus on role transitions and resolving interpersonal conflicts 1
  • Consider telemental health options when in-person care is not accessible 2

For Moderate to Severe PPD:

  • Combination therapy: Psychotherapy plus antidepressant medication 1, 4
  • First-line antidepressant: Sertraline (Zoloft) due to minimal passage into breastmilk and decades of safety data 5, 4
  • Alternative SSRIs: Paroxetine (Paxil) also shows undetectable infant serum levels 4
  • For severe cases with psychosis: Immediate psychiatric referral 4

Step 3: Consider Emerging Treatments for Treatment-Resistant Cases

  • Brexanolone (IV synthetic allopregnanolone) for rapid reduction in depressive symptoms 6
  • Repetitive transcranial magnetic stimulation for women concerned about medication exposure during breastfeeding 4

Special Considerations

Breastfeeding Mothers

  • Most antidepressants are considered compatible with breastfeeding 5
  • Discuss with patient:
    • Benefits of breastfeeding
    • Risks of antidepressant use during lactation
    • Risks of untreated illness 4

Telemental Health Options

  • Phone-based supportive interventions have shown efficacy in reducing PPD symptoms 2
  • Consider virtual care options to enhance accessibility, particularly for mothers with barriers to in-person treatment 5

Common Pitfalls to Avoid

  • Failing to distinguish between postpartum blues (first 10 days, self-resolving) and clinical PPD requiring intervention 1
  • Overreliance on single-domain assessment tools rather than comprehensive evaluation 1
  • Neglecting social support interventions as part of treatment 1
  • Assuming PPD is solely due to hormonal changes rather than recognizing its complex biopsychosocial nature 1
  • Delaying treatment, which can negatively impact maternal wellbeing and child cognitive, behavioral, and emotional development 6

Early identification and prompt treatment of PPD are essential for optimal maternal, infant, and family outcomes. The treatment approach should be guided by symptom severity, with psychotherapy as the foundation and medication added for moderate to severe cases.

References

Guideline

Postpartum Depression Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of postpartum depression.

Journal of midwifery & women's health, 2013

Related Questions

What medication is approved for treatment of suspected postpartum depression (PPD) in a 2-month postpartum female patient with depressed mood, increased appetite, difficulty sleeping, feelings of worthlessness, anxiety, and difficulty focusing at work?
What is the appropriate management for a postpartum patient with symptoms of fatigue, frequent crying episodes, feeling overwhelmed, and mood swings, who is 2 weeks postpartum, breastfeeding, and has good social support, without suicidal or homicidal ideation?
What is the next step for a 32-year-old postpartum patient with no psychiatric history, presenting with symptoms of depression 6 weeks after giving birth and an Edinburgh Postnatal Depression Scale (EPDS) score of 20?
What is the recommended pharmacological management for postpartum depression (PPD), particularly in breastfeeding mothers?
What are the treatment options for postpartum depression (PPD)?
What is tartrazine?
Is a TIRADS (Thyroid Imaging Reporting and Data System) 4 thyroid nodule a contraindication to taking Reypulses?
What is the recommended dosing of Januvia (sitagliptin) including renal dose adjustments for patients with impaired renal function?
What are the recommendations for using semaglutide (glucagon-like peptide-1 receptor agonist) in patients with a Thyroid Imaging Reporting and Data System (TIRADS) 4 thyroid nodule?
Is tartrazine consumption dangerous for people, especially those with a history of allergies or asthma?
Why does Polycystic Ovary Syndrome (PCOS) cause longer menstrual cycles?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.